CSTL Relative Valuation - Castle Biosciences Inc

Watchlist Manager

Watchlist

Price: 24.55 USD 4.25% Market Closed

Market Cap: $729.9m

	Castle Biosciences Inc NASDAQ:CSTL	US
T	Trident Texofab Ltd BSE:540726	IN
K	Kronox Lab Sciences Ltd NSE:KRONOX	IN
	Andrews Sykes Group PLC LSE:ASY	UK

Multiples-Based Value

The Multiples-Based Value of one CSTL stock under the Base Case scenario is hidden USD. Compared to the current market price of 24.55 USD, Castle Biosciences Inc is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

CSTL Multiples-Based Value

Unlock

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Castle Biosciences Inc NASDAQ:CSTL	728.8m USD	2.1	-30.2	-221.5	-10.5
US		CVS Health Corp NYSE:CVS	91.3B USD	0.2	51.6	13.5	13.5
US	C	Cigna Group XMUN:CGN	66.4B EUR	0.3	13.1	7.7	9.8
US		Cigna Corp NYSE:CI	70.3B USD	0.3	11.8	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25B EUR	1.1	19.9	9.4	14
DE		Fresenius Medical Care AG XMUN:FME	22.9B EUR	1.2	23.4	9	16.7
US		Quest Diagnostics Inc NYSE:DGX	21.6B USD	2	21.8	11.8	15.9
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	25	12	17.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.8B EUR	0.5	11	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	12.1B USD	12.3	-29	-31.7	-28.8
US		DaVita Inc NYSE:DVA	10.5B USD	0.8	14.1	7.2	9.8

				Revenue Growth	P/S to Growth
US		Castle Biosciences Inc NASDAQ:CSTL	Average P/S: 2 2.1	8%	0.3
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	12.3	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
US		Castle Biosciences Inc NASDAQ:CSTL	Average P/E: 21.3 Negative Multiple: -30.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	51.6	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.8	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.9	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.4	16%	1.5
US		Quest Diagnostics Inc NYSE:DGX	21.8	12%	1.8
US		Laboratory Corporation of America Holdings NYSE:LH	25	27%	0.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29	N/A	N/A
US		DaVita Inc NYSE:DVA	14.1	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
US		Castle Biosciences Inc NASDAQ:CSTL	Average EV/EBITDA: 9.5 Negative Multiple: -221.5	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.5	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.4	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	9	7%	1.3
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
US		Laboratory Corporation of America Holdings NYSE:LH	12	10%	1.2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -31.7	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
US		Castle Biosciences Inc NASDAQ:CSTL	Average EV/EBIT: 13.4 Negative Multiple: -10.5	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.5	22%	0.6
US	C	Cigna Group XMUN:CGN	9.8	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.7	11%	1.5
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
US		Laboratory Corporation of America Holdings NYSE:LH	17.4	18%	1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.8	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

Castle Biosciences Inc
NASDAQ:CSTL

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

CSTL Competitors Multiples
Castle Biosciences Inc Competitors

See Also

Company

Help

Tools

Stocks

Castle Biosciences Inc NASDAQ:CSTL

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

CSTL Competitors Multiples Castle Biosciences Inc Competitors

See Also

Company

Help

Tools

Stocks

Castle Biosciences Inc
NASDAQ:CSTL

CSTL Competitors Multiples
Castle Biosciences Inc Competitors